share_log

Senti Biosciences | 4: Statement of changes in beneficial ownership of securities-Director COOPERSTONE BRENDA

Senti Biosciences | 4: Statement of changes in beneficial ownership of securities-Director COOPERSTONE BRENDA

Senti Biosciences | 4:持股變動聲明-董事 COOPERSTONE BRENDA
美股SEC公告 ·  07/13 04:19

牛牛AI助理已提取核心訊息

Brenda Cooperstone, a reporting person associated with Senti Biosciences, Inc. (SNTI.US), has been involved in a transaction with the company's stock. The action took place on July 10, 2024. However, the specific details regarding the nature of the transaction, including the number of shares traded, the transaction price, and the resulting shareholding, have not been disclosed in the provided announcement.
Brenda Cooperstone, a reporting person associated with Senti Biosciences, Inc. (SNTI.US), has been involved in a transaction with the company's stock. The action took place on July 10, 2024. However, the specific details regarding the nature of the transaction, including the number of shares traded, the transaction price, and the resulting shareholding, have not been disclosed in the provided announcement.
與Senti Biosciences, Inc. (SNTI.US)有關聯的報告人Brenda Cooperstone參與了公司股票的交易,該交易發生在2024年7月10日。然而,有關交易的具體細節,包括交易股數、交易價格以及由此產生的參股金融都沒有被在提供的公告中披露。
與Senti Biosciences, Inc. (SNTI.US)有關聯的報告人Brenda Cooperstone參與了公司股票的交易,該交易發生在2024年7月10日。然而,有關交易的具體細節,包括交易股數、交易價格以及由此產生的參股金融都沒有被在提供的公告中披露。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。